Simone Colgan Dunlap, Partner

Publications and Presentations

Article
Simone Colgan DunlapSimone Colgan Dunlap
"State Health Care Fraud Law: An AHLA 50-State Survey with Summaries and Links"American Health Lawyers Association, Rhode Island ChapterSimone Colgan Dunlap
Presentation "Specialty Pharmacy and the Law" McKesson Corporation By Roger Morris, Amy Peterson, Simone Colgan Dunlap and Nick Meza
Presentation "Legal Issues in Specialty Pharmacy" National Association of Specialty Pharmacy (NASP) Annual Meeting By Roger N. Morris, Amy Cotton Peterson, Simone Colgan Dunlap, co-presenters
Presentation "Pharmacy 101" McKesson Corporation By Roger Morris, Simone Colgan Dunlap and Nicholas Meza
Presentation "State Pharmacy Licensure & Compliance" NASP First Annual Specialty Pharmacy Law Conference By Roger N. Morris, Amy Cotton Peterson, Simone Colgan Dunlap, co-presenters
Presentation "Discounts, & Rewards & Loyalty Programs, Oh My" Quarles & Brady Pharmacy Law Symposium Simone Colgan Dunlap
Presentation "Specialty Pharmacy" Quarles & Brady Pharmacy Law Symposium By Simone Colgan Dunlap
Presentation "Paying for Performance: Understanding Key Issues in Risk Sharing Agreements" Q1 Productions: Specialty Pharmaceutical Reimbursement and Market Access Conference By Simone Colgan Dunlap
Article "The Cost of Coupons: Implications of Recent OIG Guidance on Pharmaceutical Manufacturer Copayment Coupons" America Health Lawyers Association Weekly By Simone Colgan Dunlap
Article "Pharmacy Law—Examination and Board Review: Arizona Chapter" 2015 Textbook, McGraw Hill Education By Simone Colgan Dunlap, Roger N. Morris
Presentation "Health Care Reform: A Look Back and A Way Forward" Featured panelist for Greater Phoenix Chamber of Commerce seminar By Simone Colgan Dunlap
Article "Summary of Fraud and Abuse Statutes and Regulations, Rhode Island" American Health Lawyers Association By Simone Colgan Dunlap
Article "Health Law" Annual Survey of Wisconsin Law By Simone Colgan Dunlap
Article "Federal District Court in Eleventh Circuit Holds that Failure to Allege Actual Submission of a Specific False Claim is Fatal to an Off-Label Use Marketing Qui Tam Suit" American Society for Pharmacy Law: Rx Ipsa Loquitur, vol. 35, p. 2 By Simone Colgan Dunlap